Upperton Pharma Solutions
Myles Terrey is an experienced professional in the pharmaceutical and chemical industries, currently serving as a Sales Manager at Upperton Pharma Solutions since July 2023. Previously, Terrey held the position of Inside Sales Account Manager at VWR, part of Avantor, from June 2022 to June 2023. Prior to that, Terrey was a Senior Research Chemist II at Charnwood Molecular from November 2018 to June 2022 and worked as a Laboratory Demonstrator at Nottingham Trent University from October 2015 to October 2018. Terrey holds a Doctor of Philosophy (PhD) in Organic Chemistry from Nottingham Trent University, obtained between 2015 and 2019, and a Bachelor's degree in Chemistry from the same institution, completed in 2015.
Upperton Pharma Solutions
Upperton Pharma Solutions is a specialist CDMO (contract development and manufacturing organisation) providing formulation and dosage form development services to the biotechnology and pharmaceutical industries. We offer our clients a complete development service, from early feasibility studies to process optimisation, scale up and clinical trial (GMP / IMP) manufacturing. We are able to enhance the performance and delivery of our client’s products by utilising an extensive range of formulation technologies. In particular we have world leading expertise and know-how in pharmaceutical spray dryings, probably the most versatile and fastest growing technology in the industry. We have experience of working with a range of dosage forms and the expertise to develop the most challenging of molecules. Our formulation work is supported by a comprehensive range of analytical services for product testing and ICH stability studies. Upperton has an extensive, multinational client-base, ranging from virtual and small start-ups to global pharma companies. We pride ourselves on our client-focused, flexible approach and scientific excellence.